New Immunotherapy Delivery Option for Leptomeningeal Disease in Cancer Patients
University of Texas MD Anderson Cancer Center
Concurrent intrathecal and intravenous treatment is safe and improves outcomes in a subset of patients with melanoma
Further research can alter the prognosis and improve quality of life in patients with leukemia